U S ENERGY CORP - DELAWARE (USEG)

US9118053076 - Common Stock

1.53  +0.04 (+2.68%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to USEG. USEG was compared to 205 industry peers in the Oil, Gas & Consumable Fuels industry. USEG has a bad profitability rating. Also its financial health evaluation is rather negative. USEG has a expensive valuation and it also scores bad on growth.



1

1. Profitability

1.1 Basic Checks

USEG had negative earnings in the past year.
In the past year USEG had a positive cash flow from operations.
In the past 5 years USEG always reported negative net income.
In multiple years USEG reported negative operating cash flow during the last 5 years.

1.2 Ratios

USEG's Return On Assets of -13.28% is on the low side compared to the rest of the industry. USEG is outperformed by 90.69% of its industry peers.
The Return On Equity of USEG (-21.71%) is worse than 83.82% of its industry peers.
Industry RankSector Rank
ROA -13.28%
ROE -21.71%
ROIC N/A
ROA(3y)-20.86%
ROA(5y)-15.73%
ROE(3y)-29.69%
ROE(5y)-21.8%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 14.99%, USEG is doing worse than 69.61% of the companies in the same industry.
USEG's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for USEG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 14.99%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.55%
GM growth 5Y-1.99%

3

2. Health

2.1 Basic Checks

USEG does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for USEG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of -1.30, we must say that USEG is in the distress zone and has some risk of bankruptcy.
USEG has a Altman-Z score of -1.30. This is in the lower half of the industry: USEG underperforms 76.47% of its industry peers.
The Debt to FCF ratio of USEG is 0.87, which is an excellent value as it means it would take USEG, only 0.87 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of USEG (0.87) is better than 88.24% of its industry peers.
A Debt/Equity ratio of 0.18 indicates that USEG is not too dependend on debt financing.
The Debt to Equity ratio of USEG (0.18) is better than 68.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 0.87
Altman-Z -1.3
ROIC/WACCN/A
WACC8.84%

2.3 Liquidity

USEG has a Current Ratio of 0.55. This is a bad value and indicates that USEG is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of USEG (0.55) is worse than 84.31% of its industry peers.
A Quick Ratio of 0.55 indicates that USEG may have some problems paying its short term obligations.
With a Quick ratio value of 0.55, USEG is not doing good in the industry: 80.39% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.55
Quick Ratio 0.55

2

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-43.29%

3.2 Future

Based on estimates for the next years, USEG will show a very strong growth in Earnings Per Share. The EPS will grow by 22.82% on average per year.
USEG is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.33% yearly.
EPS Next Y44.47%
EPS Next 2Y37.97%
EPS Next 3Y22.82%
EPS Next 5YN/A
Revenue Next Year-37.02%
Revenue Next 2Y-16.72%
Revenue Next 3Y0.33%
Revenue Next 5YN/A

3.3 Evolution

2

4. Valuation

4.1 Price/Earnings Ratio

USEG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for USEG. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

69.61% of the companies in the same industry are cheaper than USEG, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of USEG indicates a rather cheap valuation: USEG is cheaper than 92.65% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 3.12
EV/EBITDA 12.78

4.3 Compensation for Growth

A more expensive valuation may be justified as USEG's earnings are expected to grow with 22.82% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.97%
EPS Next 3Y22.82%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.76%, USEG is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 7.14, USEG pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.36, USEG pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.76%

5.2 History

USEG is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

USEG has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-12.32%
EPS Next 2Y37.97%
EPS Next 3Y22.82%

U S ENERGY CORP - DELAWARE

NASDAQ:USEG (12/24/2024, 7:43:25 PM)

1.53

+0.04 (+2.68%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-12 2024-11-12/bmo
Earnings (Next)N/A N/A
Inst Owners2.43%
Inst Owner Change-4.27%
Ins Owners8.52%
Ins Owner Change0.06%
Market Cap42.79M
Analysts82.5
Price Target2.55 (66.67%)
Short Float %0.5%
Short Ratio0.28
Dividend
Industry RankSector Rank
Dividend Yield 7.76%
Dividend Growth(5Y)N/A
DP-12.32%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-297.6%
Min EPS beat(2)-586.27%
Max EPS beat(2)-8.93%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-7.58%
Min Revenue beat(2)-19.92%
Max Revenue beat(2)4.76%
Revenue beat(4)1
Avg Revenue beat(4)-10%
Min Revenue beat(4)-19.92%
Max Revenue beat(4)4.76%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)15.38%
PT rev (3m)42.86%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.21
P/FCF 3.12
P/OCF 7.95
P/B 0.65
P/tB 0.65
EV/EBITDA 12.78
EPS(TTM)-1.1
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)0.49
FCFY32.08%
OCF(TTM)0.19
OCFY12.57%
SpS1.26
BVpS2.37
TBVpS2.37
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.28%
ROE -21.71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 14.99%
FCFM 38.83%
ROA(3y)-20.86%
ROA(5y)-15.73%
ROE(3y)-29.69%
ROE(5y)-21.8%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.55%
GM growth 5Y-1.99%
F-Score4
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 0.87
Debt/EBITDA 2.93
Cap/Depr 77.31%
Cap/Sales 23.61%
Interest Coverage N/A
Cash Conversion 131.22%
Profit Quality N/A
Current Ratio 0.55
Quick Ratio 0.55
Altman-Z -1.3
F-Score4
WACC8.84%
ROIC/WACCN/A
Cap/Depr(3y)147.47%
Cap/Depr(5y)147.07%
Cap/Sales(3y)19.84%
Cap/Sales(5y)17.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80%
EPS Next Y44.47%
EPS Next 2Y37.97%
EPS Next 3Y22.82%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-43.29%
Revenue Next Year-37.02%
Revenue Next 2Y-16.72%
Revenue Next 3Y0.33%
Revenue Next 5YN/A
EBIT growth 1Y-379.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year4.58%
EBIT Next 3Y-16.58%
EBIT Next 5Y19.39%
FCF growth 1Y760.1%
FCF growth 3Y153.99%
FCF growth 5YN/A
OCF growth 1Y2931.58%
OCF growth 3Y157.29%
OCF growth 5YN/A